Clinical Trial

A Non-interventional Study to Evaluate the Anti-inflammatory Effects and the Clinical Efficacy of Topical Water Free Cyclosporin 0.1% Eye Drops in Patients With Dry Eye Disease and Associated Ocular Surface Inflammation Non-responding to Artificial Tears: the FOCUS Study

Completed Phase 4
View on ClinicalTrials.gov →
Summary
The FOCUS study aims to evaluate the clinical efficacy of 0.1% cyclosporine eye drops solution (Vevizye®, Laboratoires THEA) in patients with moderate to severe dry eye disease characterized by ocular surface inflammation.
Protocol Amendment History 7 changes
critical Trial completed 2026-06-28
notable Primary completion pushed: 2026-05-04 -> 2026-06-09 2026-05-24
minor Completion pushed: 2026-05-04 -> 2026-06-09 2026-05-24
critical Trial terminated 2026-05-09
critical Reason stopped changed: — → This study was not halted prematurely. This record represents a duplicate entry and has therefore been withdrawn. The correct and complete study information can be found under identifier NCT07234318. 2026-05-09
notable Primary completion moved earlier: 2026-07 -> 2026-05-04 2026-05-09
minor Completion moved earlier: 2027-01 -> 2026-05-04 2026-05-09
Trial Details
NCT Number NCT07463950
Lead Sponsor Medical University of Vienna
Conditions Dry Eye Disease (DED)
Enrollment 25 participants
Start Date 2026-01-20
Primary Completion 2026-06-01 (estimated)
Study Completion 2026-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-22